Zelira Therapeutics Ltd Investor Webinar Transcript
Good afternoon, everybody, and good evening in the US. Thank you very much for joining us today for this group webinar by Zelira Therapeutics. We have Chairman Osagie Imasogie and Global CEO Oludare Odumosu presenting to us today off the back of the announcement this morning, which many of you will have seen, regarding the results that have come out in relation to Zelira's diabetic nerve pain drug outperforming a big pharma drug.
I don't want to take all the limelight away from the two of you, because I know you're very excited. So I'll hand across to you, Osagie, to do a brief intro, and then Dare can take us through the slides. (Operator Instructions). So Osagie, I'll hand over to you. Thank you.
Thank you very much, Ronn. I appreciate that. Good morning for those in Australia, and good evening for those of our shareholders in the US. As Ronn said, we're quite pleased to have this dialogue after the results we just announced. You know, the normal
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
